Cargando…
CD19 chimeric antigen receptor T-cell therapy in adult patients with Philadelphia chromosome-positive acute lymphoblastic leukemia without complete molecular response at 3 months
| Autores principales: | , , , , , , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Nature Publishing Group UK
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10172178/ https://www.ncbi.nlm.nih.gov/pubmed/37164955 http://dx.doi.org/10.1038/s41408-023-00848-0 |
| _version_ | 1785039568336060416 |
|---|---|
| author | Yao, Zhenzhen Gu, Bin Chen, Jia Xu, Yang Chen, Feng Xue, Shengli Qiu, Huiying Tang, Xiaowen Han, Yue Chen, Suning Sun, Aining Yu, Lei Zhang, Yanming Wu, Depei Wang, Ying |
| author_facet | Yao, Zhenzhen Gu, Bin Chen, Jia Xu, Yang Chen, Feng Xue, Shengli Qiu, Huiying Tang, Xiaowen Han, Yue Chen, Suning Sun, Aining Yu, Lei Zhang, Yanming Wu, Depei Wang, Ying |
| author_sort | Yao, Zhenzhen |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-10172178 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2023 |
| publisher | Nature Publishing Group UK |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-101721782023-05-12 CD19 chimeric antigen receptor T-cell therapy in adult patients with Philadelphia chromosome-positive acute lymphoblastic leukemia without complete molecular response at 3 months Yao, Zhenzhen Gu, Bin Chen, Jia Xu, Yang Chen, Feng Xue, Shengli Qiu, Huiying Tang, Xiaowen Han, Yue Chen, Suning Sun, Aining Yu, Lei Zhang, Yanming Wu, Depei Wang, Ying Blood Cancer J Correspondence Nature Publishing Group UK 2023-05-10 /pmc/articles/PMC10172178/ /pubmed/37164955 http://dx.doi.org/10.1038/s41408-023-00848-0 Text en © The Author(s) 2023 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . |
| spellingShingle | Correspondence Yao, Zhenzhen Gu, Bin Chen, Jia Xu, Yang Chen, Feng Xue, Shengli Qiu, Huiying Tang, Xiaowen Han, Yue Chen, Suning Sun, Aining Yu, Lei Zhang, Yanming Wu, Depei Wang, Ying CD19 chimeric antigen receptor T-cell therapy in adult patients with Philadelphia chromosome-positive acute lymphoblastic leukemia without complete molecular response at 3 months |
| title | CD19 chimeric antigen receptor T-cell therapy in adult patients with Philadelphia chromosome-positive acute lymphoblastic leukemia without complete molecular response at 3 months |
| title_full | CD19 chimeric antigen receptor T-cell therapy in adult patients with Philadelphia chromosome-positive acute lymphoblastic leukemia without complete molecular response at 3 months |
| title_fullStr | CD19 chimeric antigen receptor T-cell therapy in adult patients with Philadelphia chromosome-positive acute lymphoblastic leukemia without complete molecular response at 3 months |
| title_full_unstemmed | CD19 chimeric antigen receptor T-cell therapy in adult patients with Philadelphia chromosome-positive acute lymphoblastic leukemia without complete molecular response at 3 months |
| title_short | CD19 chimeric antigen receptor T-cell therapy in adult patients with Philadelphia chromosome-positive acute lymphoblastic leukemia without complete molecular response at 3 months |
| title_sort | cd19 chimeric antigen receptor t-cell therapy in adult patients with philadelphia chromosome-positive acute lymphoblastic leukemia without complete molecular response at 3 months |
| topic | Correspondence |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10172178/ https://www.ncbi.nlm.nih.gov/pubmed/37164955 http://dx.doi.org/10.1038/s41408-023-00848-0 |
| work_keys_str_mv | AT yaozhenzhen cd19chimericantigenreceptortcelltherapyinadultpatientswithphiladelphiachromosomepositiveacutelymphoblasticleukemiawithoutcompletemolecularresponseat3months AT gubin cd19chimericantigenreceptortcelltherapyinadultpatientswithphiladelphiachromosomepositiveacutelymphoblasticleukemiawithoutcompletemolecularresponseat3months AT chenjia cd19chimericantigenreceptortcelltherapyinadultpatientswithphiladelphiachromosomepositiveacutelymphoblasticleukemiawithoutcompletemolecularresponseat3months AT xuyang cd19chimericantigenreceptortcelltherapyinadultpatientswithphiladelphiachromosomepositiveacutelymphoblasticleukemiawithoutcompletemolecularresponseat3months AT chenfeng cd19chimericantigenreceptortcelltherapyinadultpatientswithphiladelphiachromosomepositiveacutelymphoblasticleukemiawithoutcompletemolecularresponseat3months AT xueshengli cd19chimericantigenreceptortcelltherapyinadultpatientswithphiladelphiachromosomepositiveacutelymphoblasticleukemiawithoutcompletemolecularresponseat3months AT qiuhuiying cd19chimericantigenreceptortcelltherapyinadultpatientswithphiladelphiachromosomepositiveacutelymphoblasticleukemiawithoutcompletemolecularresponseat3months AT tangxiaowen cd19chimericantigenreceptortcelltherapyinadultpatientswithphiladelphiachromosomepositiveacutelymphoblasticleukemiawithoutcompletemolecularresponseat3months AT hanyue cd19chimericantigenreceptortcelltherapyinadultpatientswithphiladelphiachromosomepositiveacutelymphoblasticleukemiawithoutcompletemolecularresponseat3months AT chensuning cd19chimericantigenreceptortcelltherapyinadultpatientswithphiladelphiachromosomepositiveacutelymphoblasticleukemiawithoutcompletemolecularresponseat3months AT sunaining cd19chimericantigenreceptortcelltherapyinadultpatientswithphiladelphiachromosomepositiveacutelymphoblasticleukemiawithoutcompletemolecularresponseat3months AT yulei cd19chimericantigenreceptortcelltherapyinadultpatientswithphiladelphiachromosomepositiveacutelymphoblasticleukemiawithoutcompletemolecularresponseat3months AT zhangyanming cd19chimericantigenreceptortcelltherapyinadultpatientswithphiladelphiachromosomepositiveacutelymphoblasticleukemiawithoutcompletemolecularresponseat3months AT wudepei cd19chimericantigenreceptortcelltherapyinadultpatientswithphiladelphiachromosomepositiveacutelymphoblasticleukemiawithoutcompletemolecularresponseat3months AT wangying cd19chimericantigenreceptortcelltherapyinadultpatientswithphiladelphiachromosomepositiveacutelymphoblasticleukemiawithoutcompletemolecularresponseat3months |